Curriculum Vitae Ramzi K - University of Maryland School ...



Curriculum Vitae

Ramzi K. Hemady, M.D.

Associate Professor, Department of Ophthalmology and Visual Sciences

University of Maryland School of Medicine

Date October, 2016

Contact Information

Business Address Department of Ophthalmology and Visual Sciences

University of Maryland School of Medicine

419 W. Redwood Street

Baltimore, MD 21201

Business Phone Number 410-328-5933

Fax Number 410-328-6346

Email rhemady@som.umaryland.edu

Foreign Languages Arabic, French

Education

1980 B.S., Biology/Chemistry, American University of

Beirut, Beirut, Lebanon

1984 M.D. American University of Beirut, Beirut,

Lebanon

Post Graduate Training

1983-1984 Internship in Internal Medicine

American University of Beirut Medical Center

Beirut, Lebanon

1984-1987 Residency in Ophthalmology

American University of Beirut Medical Center Beirut, Lebanon

1987-1991 Fellowship in Cornea, Anterior Segment and Uveitis

Massachusetts Eye and Ear Infirmary

Harvard School of Medicine, Boston, Massachusetts

Medical Licensures

1991 State of Maryland

2008 Turks and Caicos, British West Indies

2011 Anguilla, British West Indies

Employment History

Faculty Appointments

1991-1992 Instructor, Department of Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland

1992-1998 Assistant Professor, Department of Ophthalmology

University of Maryland School of Medicine

Baltimore, Maryland

1998-present Associate Professor, Department of Ophthalmology

University of Maryland School of Medicine

Baltimore, Maryland

2006-2011 Acting Chair, Department of Ophthalmology & Visual Sciences

University of Maryland School of Medicine

Baltimore, Maryland

Other Positions

1991-1992 Consultant in Ophthalmology

Veterans Administration Hospital

Baltimore, Maryland

1992-1993 Staff Surgeon

Veterans Administration Hospital

Baltimore, Maryland

1993-2006 Chief of Ophthalmology

Veterans Administration Hospital

Baltimore, Maryland

1993-2008 Consultant in Ophthalmology

Veterans Administration Hospital

Wilmington, Delaware

1996-2006 Director VA Ophthalmic Services

Department of Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland

1996-2012 Director, Anterior Segment, Refractive Surgery,

and Uveitis Services, Department of Ophthalmology, University

of Maryland School of Medicine, Baltimore, Maryland

2001-present Attending Physician, Maryland General Hospital

Baltimore (now University of Maryland Midtown Campus), Maryland

Visiting Professorships

January 1995 Visiting Professor

American University of Beirut

April 1997 Visiting Professor

Majuro Hospital, the Marshall Islands

May 1998 Visiting Surgeon

Healing the Children Northeast, Inc.

Guayaquil, Ecuador

March 1999 Visiting Professor

American University of Beirut

March 2000 Visiting Surgeon

Project Dawn, Georgetown, Guyana

September 2000-Present Semi-Annual Visiting Surgeon

InterhealthCanada, Turks and Caicos,

British West Indies

January 2005 Invited Professor, Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University Bangkok, Thailand

January 2005 Invited Surgeon

Phra Chom Klao Hospital, Petchaburi, Thailand

November 2005 Visiting Professor

Massachusetts Eye and Ear Infirmary, Boston, Massachusetts

May 2008 Visiting Professor

Department of Ophthalmology, University of Loma Linda, California

March 2010 Visiting Surgeon

Guayaquil, Ecuador

May 2016 Visiting Professor, St James School of Medicine, Anguilla, British West Indies

Professional Memberships

1987 American Academy of Ophthalmology

1987 Association for Research and Vision in Ophthalmology

1987 American Medical Association

1987 Ocular Microbiology and Immunology Group

1988 American Uveitis Society

1991 Maryland Society of Eye Physicians and Surgeons

1992 Apex Cornea Society

1995 Associate Member, Association of University Professors

of Ophthalmology

1996 American Society of Cataract and Refractive Surgeons

2006 Member, Association of University Professors

of Ophthalmology

2008 Cornea Society

Honors and Awards

1987-1988 Fogarty International Fellow, US Public Health Service, National Institutes of Health

1987-1989 Hariri Foundation Educational Grant

1993 Lois A. Young-Thomas Award for Excellence in Teaching; awarded by the residents of the Department of Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland

1994 VA Gold Pin Award

1999 The Camille Matta Travel Fellowship, American University of Beirut Alumni

Association, Ophthalmology section

2002 Lois A. Young-Thomas Award for Excellence in Teaching; awarded by the residents of the Department of Ophthalmology, University of Maryland School of Medicine

2003 Lois A. Young-Thomas Award for Excellence in Teaching; awarded by the residents of the Department of Ophthalmology, University of Maryland School of Medicine

2004 Lois A. Young-Thomas Award for Excellence in Teaching; awarded by the residents of the Department of Ophthalmology, University of Maryland School of Medicine

2006, 2009, 2010 Surgical Mentor of the Year; awarded by the residents of the

Department of Ophthalmology, University of Maryland School of

Medicine

Clinical Activities

Perform more than 450 major anterior segment procedures/year. These include state of the art cataract surgery, combined cataract extraction and glaucoma filtering procedures, triple procedures (corneal transplantation, cataract extraction and intraocular lens placement), full and partial thickness corneal transplantation, secondary implantation of intraocular lenses, pupiloplasty, and pterygium surgery.

The first to use fibrin glue during pterygium excision in Maryland, the first to perform corneal keratoprosthesis surgery in Maryland, and the first to perform quick chop cataract surgery at the University of Maryland.

Perform more than 50 laser procedures/year including laser refractive surgery and YAG capsulotomy.

In addition, I see approximately 5,000 patients per year. These include patients with anterior segment diseases (such as corneal ulcers, keratoconus, atopy, etc.) cataracts, and uveitis.

Introduced immunosuppressive therapy in the management of uveitis at the University of Maryland.

Administrative Services

Institutional Service

1991-1997 Chief, Ocular Consultation Service Department of Ophthalmology, University of Maryland

School of Medicine, Baltimore, Maryland

1991-present Cornea Service, Department of Ophthalmology

University of Maryland School of Medicine, Baltimore, Maryland

1991-present Ocular Immunology Service, Department of Ophthalmology University of Maryland School of Medicine, Baltimore, Maryland

1991-1994 Utilization Management Committee, University of Maryland Hospital, Baltimore, Maryland

1991-1997 Advisor and Co-coordinator, Medical Students Ophthalmology

Elective Rotation, Department of Ophthalmology, University of

Maryland School of Medicine, Baltimore, Maryland

1994-2004 Operating Room Committee, University of Maryland Hospital

Baltimore, Maryland

1993-1994 Member, Search Committee for General Ophthalmologist, Department of Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland

1993-1994 Member, Search Committee for Optometrist, Department of Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland

1995-2006 Preceptor, Internal Medicine Residents' Ophthalmology Elective

Rotation, Department of Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland

1995-2006 Interviewer, Medical School Committee on Admissions,

University of Maryland School of Medicine, Baltimore, Maryland

1996-present Coordinator, Overseas Medical Services, Department of

Ophthalmology, University of Maryland, Baltimore , Maryland

1996-1997 Member, Search Committee for Oculoplastic Surgeon, Department

of Ophthalmology, University of Maryland School of Medicine, Baltimore, Maryland

1997-2007 Director of Residency Program, Department of Ophthalmology,

University of Maryland School of Medicine, Baltimore, Maryland

1997-present Member, Graduate Medical Education Committee, University of

Maryland School of Medicine, Baltimore, Maryland

2000-present Departmental Expense Committee, Department of Ophthalmology,

University of Maryland School of Medicine, Baltimore, Maryland

2006-present Member, University of Maryland School of Medicine Executive

Committee, Baltimore, Maryland

2006-present Member, Board of Trustees, University Physicians Inc.

Baltimore, Maryland

2006-present Member, Medical Executive Committee, University of Maryland

Medical Center, Baltimore, Maryland

2007-present Member, Perioperative Committee, University of Maryland

Medical System, Baltimore, Maryland

National Service

1991-present Reviewer, "Ophthalmology"

1993-present Participant, National Eye Care Project, sponsored by the American

Academy of Ophthalmology

1994-present Participant, Glaucoma 2001 Project, sponsored by the American

Academy of Ophthalmology

1994 Reviewer, Ophthalmic Genetics

1995-present Reviewer, Archives of Ophthalmology

2001-present Reviewer, British Journal of Ophthalmology

Reviewer, Ophthalmic Surgery and Lasers

2006 Reviewer, Ophthalmic Research

2007-present Reviewer, Ophthalmic Research, electronic journal

2007-present Reviewer, Eye, electronic journal

International Service

April 1997 Majuro Hospital, the Marshall Islands

May 1998 Healing the Children Northeast, Inc.

Guayaquil, Ecuador.

March 2000 Project Dawn, Georgetown, Guyana

September 2000 and 2x/year since Grand Turk Hospital, Grand Turk, Turks and Caicos

January 2005 Phra Chom Klao Hospital, Petchaburi, Thailand

March 2010 Guayaquil, Ecuador

Grant Support/Clinical Trials

1992 Co-investigator "Timpilo: fixed combination vs. concomitant

therapy. Merck, Sharp and Dohme Research Laboratories.

1992 Co-investigator "A supplemental clinical evaluation of the safety and

efficacy of yellow mercuric oxide vs placebo in the treatment of blepharitis. Del Pharmaceuticals, Inc.

1992 Co-investigator "Adjunctive therapy with Galardin matrix

metalloproteinase inhibitor in patients with corneal ulcers caused by

Rheumatoid Arthritis. Glycomed Inc.

1992 Co-investigator "Adjunctive therapy with Galardin matrix

metalloproteinase inhibitor in patients with corneal ulcers caused by infection. Glycomed Inc.

1992 Co-investigator "Intermittent intravenous Suramin in patients with

advanced incurable malignancies", National Institutes of Health.

1994 Co-investigator "Randomized study comparing the safety and efficacy of

three doses of oral ganciclovir to intravenous ganciclovir for the maintenance treatment of cytomegalovirus retinitis in people with AIDS". Syntex research.

1995 Co-investigator "Ocular hypertension treatment study (OHTS). National

Institutes of Health

1995 Co-investigator "Phase II clinical trial of 4-Hydroxyphenyl Retinamide in

oral leukoplakia", National Cancer Institute.

1996 Sub-investigator "Comparison of safety and efficacy of Lotemax and

Prednisolone acetate in acute anterior uveitis". Pharmos Corp.

1997 Principal investigator “Comparative evaluation of corrected and

uncorrected visual acuities and quality of life after implantation of the Cee-on 912 or Acrysof MA30BM foldable intraocular lens”. Pharmacia and Upjohn.

1997 Principal investigator “A 1-year, double masked, randomized, 3-arm

parallel group study comparing the effect of 0.005% latanoprost and fixed combination 0.005% latanoprost-0.5% timolol eye drops to 0.05% timolol on corneal endothelial cell counts and corneal thickness in patients with open angle glaucoma or ocular hypertension”. Pharmacia and Upjohn.

1999 Principle investigator “Multicenter, investigator masked study evaluating

the safety and efficacy of cyclosporine 0.05% ophthalmic emulsion for up

to six months in patients with mild to moderate keratoconjunctivitis sicca”. Allergan.

2000-2006 Sub-investigator “Multicenter, randomized, masked, controlled study to

evaluate the safety and efficacy of memantine in patients with chronic

open angle glaucoma at risk for progression”. Allergan.

2006 Principal Investigator, Ocular Hypertension Treatment Study (OHTS II).

National Institutes of Health

Publications

Peer Reviewed Journal Articles

1. Khawam E, Azar D, Shami M, Hemady R. Progressive familial ophthalmoplegia with optic nerve coloboma: Report of a family. Binocular Vision 2:223, 1987.

2. Marouf LM, Azar DT, Hemady R, Salamoun SG. Orbital echinococcosis in unilateral exophthalmos. Orbit 6:213, 1987.

3. Hemady R, Opremcak EM, Zaltas M, Berger A, Foster CS. Herpes simplex type1 strain influence on chorioretinal disease patterns following intracameral inoculation in Igh-1 disparate mice. Invest Ophthalmol Vis Sci 30:1750, 1989.

4. Opremcak EM, Foster CS, Hemady R, Rice BA, Daigle JA, Raizman MB, Chung H, Zaltas M. Chorioretinal disease patterns in congenic mice following intraocular inoculation with HSV-1. Invest Ophthalmol Vis Sci 30:1041, 1989.

5. Hemady R, Zaltas M, Paton B, Foster CS, Baker AM Bacillus-induced endophthalmitis, new series of 10 cases and review of the literature. Br J Ophthalmol 74:26, 1990.

6. Hemady R, Foster CS. Anterior chamber crystals following hyphema. Arch Ophthalmol 108:14, 1990.

7. Hemady R, Chu W, Foster CS. Keratoconjunctivitis sicca and corneal ulcers. Cornea 9:170, 1990.

8. Hemady R, Wagoner M, Bajart AM. Interface abscess after epikeratophakia. Am J Ophthalmol 109:735, 1990.

9. Hemady R, Tauber J, Ihley TM, Opremcak EM, Foster CS. Viral isolation and systemic immune responses after intracameral inoculation of herpes simplex type-1 in Igh-1 disparate congenic murine strains. Invest Ophthalmol Vis Sci 31:2335, 1990.

10. Hemady R, Tauber J, Foster CS. Immunosuppressive drugs in immune and inflammatory ocular disease. Surv Ophthalmol 35:369, 1991.

11. Zierhut M, Tamesis R, Hemady R, Foster CS. Herpes-simplex-virus-retinitis. Fortschr Ophthalmol 88:740, 1991.

12. Zaltas MM, Opremcak EM, Hemady R, Foster CS. Immunohistopathologic findings in herpes simplex virus chorioretinitis in the von Szily model. Invest Ophthalmol Vis Sci 33:68, 1992.

13. Hemady RK, Baer JC, Foster CS. Immunosuppressive drugs in the management of progressive, corticosteroid-resistant, uveitis associated with juvenile rheumatoid arthritis. Int Ophthalmol Clin 32:241, 1992.

14. Hemady R, Chu W, Foster CS. Intraocular penetration of ketoconazole in rabbits. Cornea 11:329, 1992.

15. Hemady R, Sainz de la Maza M, Raizman MB, Foster CS. Six cases of scleritis

associated with systemic infections. Am J Ophthalmol 114:55, 1992.

16. Hemady R, Zimmerman A, Katzen BW, Karesh JW. Orbital cellulitis caused by Eikenella corrodens. Am J Ophthalmol 114:584, 1992.

17. Aristimuno B, Nirankari VS, Hemady RK, Rodrigues MM. Spontaneous ulcerative keratitis in immunocompromised patients. Am J Ophthalmol 115:202, 1993.

18. Hemady RK, Blum S, Sylvia B. Duplication of the lens, hour glass cornea, and cornea plana. Arch Ophthalmol 111:303, 1993.

19. Hemady RK, Baer JC, Foster CS. Biomicroscopic and histopathologic observations after corneal laser photocoagulation in a rabbit model of corneal neovascularization. Cornea 12:185, 1993.

20. Hemady RK, Griffin N, Aristimuno B. Recurrent corneal infections in a patient with the acquired immunodeficiency syndrome. Cornea 12:266, 1993.

21. De La Maza MS, Hemady RK, Foster CS. Infectious scleritis: report of four cases. Doc Ophthalmol 83:33, 1993.

22. Patel AS, Hemady RK, Rodrigues M, Rajagopalan S, Elman MJ. Endogenous Fusarium endophthalmitis in a patient with acute lymphocytic leukemia. Am J Ophthalmol 117:363, 1994.

23. Hemady RK, Patel A, Blum S, Nirankarii VS. Bilateral iridocorneal endothelial

syndrome: report of a case and review of the literature. Cornea 13:368, 1994.

24. Hemady RK. Ocular injuries from violence treated at an inner-city hospital. J of Trauma 37:5; 1994.

25. Hemady RK. Microbial keratitis in patients infected with the human immunodeficiency virus. Ophthalmology 102:1026, 1995.

26. Hemady RK. Bilateral endogenous bacterial endophthalmitis complicating intravenous therapy for CMV retinitis in a patient with AIDS. MEJO 3:194, 1995.

27. Eisenberger MA, Sinibaldi VJ, Reyno LM, Sridhara R, Jordell DI, Zuhowski EG, Tkaczuk KH, Lowitt MH, Hemady RK, Jacobs SC, Van Echo D, Egorin MJ. Phase-1 and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone refractory prostate cancer. J Clin Oncol 13:2174, 1995.

28. Hemady RK, Sinibaldi V, Eisenberger M. Ocular symptoms and signs associated with suramin treatment for metastatic cancer of the prostate. Am J Ophthalmol 121:291, 1996.

29. Conley BA, Egorin MJ, Sridhara R, Finley R, Hemady R, Wu S, Tait NS, Van Echo DA. Phase I clinical trial of all-trans-retinoic acid with correlation of pharmacokinetics and pharmacodynamics. Cancer Chemother Pharmacol, 39:291,1997.

30. Merchant A, Fletcher J, Medina CA, Hemady RK, Foster CS. Pharmacomanipulation of HSV-1 induced chorioretinitis in mice. Eye 11(Pt4):504, 1997.

31. Liu SM, Su J, Hemady, RK. Corneal melting after avulsion of a Molteno shunt plate. J Glaucoma, 6:357, 1997.

32. Biehl JW, Valdez J, Hemady RK, Steidl SM, Bourke DL. Penetrating eye injury in war. Military Medicine, 164:1, 1999.

33. Rutzen AR, Deen H, Epstein AJ, Maldonado MJ, Hemady RK. Cataract surgery in a patient with Brown-McLean syndrome. J Cataract Refract Surg 27:1335, 2001.

34. Koh SW, Rutzen A, Coll T, Hemady R, Higginbotham EJ. VIP immunoreactivity in human aqueous humor. Curr Eye Res 30:89, 2005.

35. Rutzen AR, Ellish NJ, Schwab L, Graham PJ, Pizzarello LD, Hemady RK, Maldonado MJ. Blindness and eye disease in Cambodia. Ophthalmic Epidemiology 14(6):360, 2007.

Non-Peer Reviewed Articles

1. Contributor, “Ophthalmology Capsule and Comment”. 1998-2004.

2. AIDS related corneal infections. OSN, 17: 35, 1999.

Book Chapters

1. Foster CS, Ihley TM, Hemady R, Tamesis RR, Rice BA, Wells, PA. In Usui M, Ohno S, Aoki K, eds. Role of antibody in prevention of herpes simplex stromal keratitis. Ocular Immunology Today. Elsevier Science Publishers BV, Amsterdam, the Netherlands. 111- 114, 1990.

2. Hemady RK, Opremcak EM, Zaltas M, Tauber J, Foster CS. In Usui M, Ohno S, Aoki K, eds. Igh-1 influence on development of HSV-1 retinitis in a mouse model. Ocular Immunology Today. Elsevier Science Publishers BV, Amsterdam, the Netherlands. 119-122, 1990.

3. Foster CS, Hemady RK, Baer JC. Cytotoxic agents in the management of juvenile rheumatoid arthritis (JRA) associated uveitis. In Dernouchamps JP, Verougstraete C, Caspers-Velou L, Tassignon MJ, eds. Recent Advances in Uveitis. Kugler Publications, Amsterdam/New York. 525-528, 1993.

4. Karesh JW, Baer JC, Hemady R. Noninfectious orbital inflammatory disease. In Duane’s Clinical Ophthalmology. Tasman W, Jaeger EA, eds., J.B. Lippincott Company, Philadelphia. Ch. 35, 1994.

5. Baer JC, Hemady, RK. Ocular manifestations of systemic immune disease. In Principles and Practice of Ophthalmic Plastic and Reconstructive Surgery. Bosniak SL, ed, W.B. Saunders Co., Philadelphia. p. 94, 1996.

6. Hemady RK, Hormozi D. Ocular trauma. In A Clinical Guide for the Comprehensive Ophthalmologist. Lee D, Higginbotham EJ, eds., Thieme, New York. Ch 4, p85, 1998.

7. Sobol AL, Hemady, RK. Rift valley fever. In Diagnosis and Treatment of Uveitis. Foster CS, Vitale AT, eds, W.B. Saunders, Philadelphia. Ch 25, p333, 2002.

8. Hemady RK, Bernstein SL. Corneal involvement in systemic disorders. In Clinical Eye Atlas. Gold DH, Lewis LA, eds, AMA Press, Chicago. Ch 3, p400, 2002.

9. Hemady RK. Dacryoadenitis In Smolin and Thoft’s The Cornea. Foster CS, Azar DT

and Dohlman CH, eds.

10. Hemady RK, Chan AS, Nguyen AT. Immunosuppressive agents and nonsteroidal anti-

inflammatory drugs for ocular immune and inflammatory disorders. In Ophthalmol Clin

North Am. Lee DA ed. Dec;18 (4): 511, 2005.

Published Abstracts

1. Opremcak EM, Hemady R, Berger A, Foster CS. HSV-1 strain influence on chorioretinal disease patterns following intracameral inoculation in Igh-1 disparate mice. Invest Ophthalmol Vis Sci 29(suppl):151, 1988.

2. Hemady R, Opremcak EM, Foster CS. Induction of HSV-1 specific T-suppressor cells protects against contralateral destructive retinitis. Invest Ophthalmol Vis Sci 29(suppl):152, 1988.

3. Azar DT, Marouf L, Hemady R, Salamoun S. Characteristic A- and B- ultrasonographic findings in orbital hydatid disease. Ophthalmology 95(suppl):174, 1988.

4. Opremcak EM, Zaltas MM, Hemady R, Foster CS. The von-Szily model of herpes simplex virus chorioretinitis: immunohistopathology. Invest Ophthalmol Vis Sci 30(suppl):492, 1989.

5. Hemady R, Opremcak EM, Foster CS. Protection from HSV-1 induced retinitis in BALB/cByJ mice. Invest Ophthalmol Vis Sci 30(suppl):360, 1989.

6. Ihley TM, Hemady R, Wells PA, Rice B, Foster CS. Corneal inoculation with herpes simplex virus-1 (HSV-1) in conjunction with B-cell suppression enhances herpetic stromal keratitis (HSK) in normally resistant murine strains. Invest Ophthalmol Vis Sci 30(suppl):359, 1989.

7. Tauber J, Hemady R, Ihley TM, Opremcak EM, Foster CS. Systemic immunologic responses following intracameral inoculation of HSV-1 in susceptible and resistant Igh-1 disparate congenic murine strains. Invest Ophthalmol Vis Sci 30(suppl):359, 1989.

8. Neumann R, Zierhut M, Hemady R, Tamesis RR, Ihley TM, Foster CS. The role of natural killer cells in contralateral disease in the von-Szily model of HSV-1. Invest Ophthalmol Vis Sci 31(suppl):64, 1990.

9. Ihley TM, Hemady R, Foster CS. B-cell depletion enhances herpes simplex virus-1 (HSV-1) retinitis in a normally resistant murine strain. Invest Ophthalmol Vis Sci 31(suppl):223, 1990.

10. Fletcher JD, Hemady R, Sainz de la Maza M, Foster CS. Pharamacomanipulation of HSV-1 induced retinitis in BALB/cByJ mice. Invest Ophthalmol Vis Sci 31(suppl):224, 1990.

11. Hemady R, Nabavi A, Foster CS. Delayed type hypersensitivity reactions and antibody responses after anterior chamber inoculation of HSV-1 strain mP and MP in BALB/cByJ mice. Invest Ophthalmol Vis Sci 31(suppl):314, 1990.

12. Baer JC, Hemady R, Foster CS. Yellow dye laser photocoagulation of corneal neovascularization in a rabbit model: histopathology. Invest Ophthalmol Vis Sci 31(suppl):479, 1990.

13. Hemady RK, Baer JC, Foster CS. Cytotoxic agents in the management of juvenile rheumatoid arthritis (JRA) associated uveitis. Ophthalmology 97(suppl):107, 1990.

14. Azar DT, Niffenegger JH, Hemady RK, Foster CS, Chen TC, Holick MF. The effect of 1,25 (OH) vitamin D3 on rabbit corneal graft rejection. Invest Ophthalmol Vis Sci 32(suppl):780, 1991.

15. Hemady R, Sainz de la Maza M, Raizman M, Foster CS. Infectious scleritis. Ophthalmology 32(suppl):104, 1991.

16. Hemady R. Violence related ocular injuries: Report of 80 cases. Invest Ophthalmol Vis Sci 33(suppl):781, 1992.

17. Rodrigues MM, Aristimuno B, Hemady R, Nirankari VS. Infectious keratitis in immunocompromised hosts: Report of 5 cases. Invest Ophthalmol Vis Sci 33(suppl):1297, 1992.

18. Hemady RK, Baer JC. Ocular manifestations of HIV infection in adult women. Invest Ophthalmol Vis Sci 34(suppl):1109, 1993.

19. Kathuria, SS, Hemady RK, Evans D. Ophthalmic evaluation in the work-up of fever in immunosuppressed patients after organ transplantation. Invest Ophthalmol Vis Sci 34(suppl):1259, 1993.

20. Aristimuno B, Hemady RK. Ocular injuries from falls. Invest Ophthalmol Vis Sci 34(suppl):1115, 1993.

21. Hemady RK, Sinibaldi VJ, Eisenberger, MA. Ocular findings in patients treated with suramin for metastatic cancer of the prostate. Ophthalmology 101(suppl):91, 1994.

22. Dyer PK, Salvo EC, Bacal DA, Hemady RK. Ocular injuries seen at a major trauma center during one year. Invest Ophthalmol Vis Sci 37(suppl):3046, 1996.

23. Hemady RK, Katz HR, Hirschbein MJ, O’Brian TP, Goyal RK, Cunningham ET, Acharya N. Fungal keratitis in HIV-infected individuals: a multicenter report. American Academy of Ophthalmology Final Program 172, 1998.

24. Gupta P, Rutzen AR, Spinak D, Hemady RK. New onset uveitis in the elderly. Invest Ophthalmol Vis Sci 40(suppl):781, 1999.

25. Sheik ZA, Hemady RK, Rutzen AR. Comparison of topical anesthesia regimens. Invest Ophthalmol Vis Sci 40(suppl):2897, 1999.

26. Rutzen AR, Hemady RK, Sheik ZA. Corneal endothelial rejection ring in a corneal graft. Invest Ophthalmol Vis Sci 40(suppl):3346, 1999.

27. Magbalon MJ, Johnson MA, Hemady RK, Rutzen AR. Retinal pigment epithelial functional changes with Plaquenil: how much is toxic. Invest Ophthalmol Vis Sci 40(suppl):5198, 1999.

28. Hemady RK, Kearns TJ, Sobol AL. Prospective evaluation of air bag related ocular injuries. Invest Ophthalmol Vis Sci (suppl): 3056, 2002.

29. Sadri E, Jones BE, Hemady RK. Cryotherapy for treatment of cyclodialysis cleft

refractory to argon laser treatment. Invest Ophthalmol Vis Sci (suppl):4505, 2002.

30. Grace CC, Hemady RK, Griffin NB, Barker J. Pre-Cut DSAEK Tissue: How much

swelling occurs in storage and does it Matter? Invest Ophthalmol Vis Sci (suppl):49,

2008.

31. Reilly GS, Mikdashi J, Hemady RK. Early step down combination therapy with adalimumab and azathioprine in non-infectious ocular inflammation. American Academy of Ophthalmology Final Program, 2010.

Major Invited Speeches

1. "Ocular Manifestations of Sexually Transmitted Diseases", St Agnes Hospital Surgical Grand Rounds, Baltimore, Maryland, October 1991.

2. "Management of Ocular Emergencies", Family Medicine Grand Rounds and Core Lectures, University of Maryland Health Center, Baltimore, Maryland, February 1992 and 1993.

3. "Cataracts", Family Medicine Core Lectures, University of Maryland Health Center, Baltimore, Maryland, March 1993.

4. "Ophthalmology for the Primary Care Physician", Family Medicine 20th Anniversary Review Course, Ocean City, Maryland, June 1994.

5. "Basic eye health care", Nations Bank of Maryland noon time employee health lectures, Baltimore, Maryland, October 1995.

6. "Ocular hypertension vs glaucoma" at the Glaucoma Diagnosis and Management for Ophthalmic Medical Personnel meeting, Baltimore, Maryland, February 1996.

7. "Ocular emergencies for the primary care physician: recognition and management", Doctors Community Hospital Grand Rounds, Greenbelt , Maryland, September 1996.

8. "Ocular manifestations of the acquired immune deficiency syndrome", Ophthalmic personnel accredited program of the MSEPS, Columbia, Maryland, September 1996.

9. " Refractive disorders, medical and surgical approaches", Medical Grand Rounds, University of Maryland Hospital, Baltimore, December 1996.

10. " Eye Trauma", Shock Trauma Grand Rounds, Shock Trauma, Baltimore, February 1997.

11. "Complications of cataract surgery", Ophthalmic personnel accredited program of the MSEPS, Columbia, Maryland, November 1997.

12. “Evaluation of the red eye”, Ambulatory Medicine Conference, University of Maryland Hospital, Baltimore, Maryland, February 1998.

13. “Anterior segment emergencies”, Ophthalmic personnel accredited program of the MSEPS, Baltimore, Maryland, November 1998

14. “The eye in systemic diseases”, Internal Medicine Grand Rounds, York Hospital, York, Pennsylvania, October 2002

15. “Common office eye problems: recognition and management”, weekly Grand Rounds, Laurel Regional Hospital, Laurel, Maryland, October 2002

16. “The eye in systemic diseases”, weekly Grand Rounds, Doctors Community Hospital,

Greenbelt, Maryland, December 2002.

17. “The Eye in Diseases of the Skin”, Grand Rounds, Department of Dermatology,

University of Maryland School of Medicine, Baltimore, Maryland, December 2007.

18. “Presbyopia and Multifocal IOLs”, Maryland Society of Eye Physicians and Surgeons

(MSEPS) Annual Meeting, Baltimore, Maryland, May 2008.

19. “Surgical Correction of Presbyopia”, Ophthalmic Society of the West Indies (OSWI)

Annual Meeting, Montego Bay, Jamaica, July 2008.

CME Courses

1. Co-Director "Advances in laser applications for Ophthalmology", sponsored by the University of Maryland School of Medicine, Baltimore, Maryland, September 1996.

2. "Combined cataract and glaucoma", at the Special Focus Course on Phacoemulsification Techniques, sponsored by the American Academy of Ophthalmology, Arlington, Virginia, March 1997.

3. "Anterior segment findings in AIDS patients", at the Advances in Ophthalmology for the 21st Century Symposium, sponsored by Sinai Hospital, Baltimore, Maryland, April 1997.

4. " Treatment of non-diabetic CME", at the Retina for the Comprehensive Ophthalmologist meeting, sponsored by the University of Maryland School of Medicine, Baltimore, Maryland, September 1997.

5. "Laser Iridotomy", at the Advances in Laser Applications for Ophthalmology course, co-sponsored by the University of Maryland School of Medicine and the Optical Society of America, Long Beach, October 1997.

6. “Management of the small pupil in combined procedures”, at the Diagnostic and Therapeutic Advances in Glaucoma course, sponsored by the Maryland Center for Eye Care, University of Maryland School of Medicine, Baltimore, February 1998.

7. Co-director, “Cornea Day 1998”, co-sponsored by the University of Maryland School of Medicine, the Maryland Society of Eye Physicians and Surgeons, and the Medical Eye Bank of Maryland, Baltimore, March 1998.

8. “Fungal keratitis in HIV patients”, at Cornea Day 1998, co-sponsored by the University of Maryland School of Medicine, the Maryland Society of Eye Physicians and Surgeons, and the Medical Eye Bank of Maryland, Baltimore, March 1998.

9. “Laser treatment of corneal neovascularization”, at the Advances in Laser Applications for Ophthalmology workshop, co-sponsored by the University of Maryland School of Medicine and the Optical Society of America, Baltimore, October 1998.

10. “Immunosuppressive therapy of anterior segment disorders”, at Cornea Day 1999, co-sponsored by the Wilmer Eye Institute, the Maryland Society of Eye Physicians and Surgeons, and the Medical Eye Bank of Maryland, Baltimore, January 1999.

11. “Considerations in performing cataract surgery in the patient with glaucoma”, at the New Directions in Glaucoma meeting, sponsored by the University of Maryland School of Medicine, Baltimore, February 2000.

12. “Cataract extraction in uveitis”, at the annual Hoover/Naquin conference, sponsored by the Greater Baltimore Medical Center, Baltimore, March 2000.

13. “Cataract extraction in patients with uveitis”, at the 10th Anniversary Symposium of the Krieger Eye Institute, Baltimore, June 2001.

14. “Phacoemulsification under special circumstances: Diabetes mellitus, uveitis, glaucoma,

and Fuchs endothelial dystrophy. Hemady RK. Rutzen AR, Nguyen TQA. The annual meeting of the American Academy of Ophthalmology, Anaheim, CA, November 2003.

15. Stress-Free Step-by-step system of teaching phacoemulsification skills to beginners.

Hemady RK and Rutzen AR. The annual meeting of the American Society of Cataract

and Refractive Surgery, San Diego, CA, May 2004.

16. Senior Instructor “Phacoemulsification under special circumstances: Diabetes mellitus,

uveitis, Fuchs endothelial dystrophy, and glaucoma”. At the 2003 annual meeting of the

American Academy of Ophthalmology, Anaheim, California.

17. Senior Instructor “Phacoemulsification under special circumstances: Diabetes mellitus,

uveitis and glaucoma:. At the October 2004 annual meeting of the American Academy

of Ophthalmology, New Orleans, Louisiana.

18. Senior Instructor “A stress –free step-by-step system of teaching phacoemulsification skills to beginners”. The 2004 annual meeting of the American Society for Cataract and Refractive Surgery, San Diego, California.

19. Faculty “Keratorefractive surgery and corneal disease: Tackling the challenging cases.” The Maryland Medical Convention, Cambridge, MD October 2004.

20. Senior Instructor “Phacoemulsification under special circumstances: Diabetes mellitus,

uveitis, and glaucoma.’ The October 2005 annual meeting of the American Academy of

Ophthalmology, Chicago, IL.

Proffered Communications

1. Aristimuno B, Nirankari VS, Hemady RK, Rodrigues MM. Spontaneous ulcerative keratitis in intravenous drug abusers. At the 25th annual meeting of the Ocular Microbiology and Immunology Group, Anaheim, October 1991.

2. Hemady RK. Microbial keratitis in patients infected with the human immunodeficiency virus. At the 28th annual meeting of the Ocular Microbiology and Immunology Group, San Francisco, October 1994.

3. Hemady RK, Katz HR, Hirschbein M. Fungal keratitis in HIV infected individuals. At the 31st annual meeting of the Ocular Microbiology and Immunology Group, San Francisco, October 1997.

4. Nguyen ATQ, Hemady RK. Safety and efficacy of trans-septal triamcinolone injections for intraocular inflammation. Presented at the annual meeting of the American Uveitis Society, Vail, Colorado, January 2001.

5. Hemady RK, Gupta G. Safety and efficacy of acrylic foldable intraocular lenses in patients with uveitis. Presented at the annual meeting of the American Uveitis Society, Vail, Colorado, January 2002.

6. Hemady RK, Elhosn R, Squires A, Emmert-Buck L. Topical linezolid for the treatment of vancomycin-resistant enterococcus keratitis after penetrating keratoplasty. Presented at the annual meeting of the American Society of Cataract and Refractive Surgery, San Diego, CA, May 2004.

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download